Concomitant medication
Sponsors
GWT-TUD GmbH, Abteilung Medizin, Leberstiftungs-GmbH Deutschland, Janssen Research & Development, LLC, Code Pharma
Conditions
D80.3HIVHIV InfectionLupus Erythematosus, SystemicSLD (K76.-), MASLD, MASH, ALD (K70.-), MetALD
K76
K70
Phase 2
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
CompletedNCT02349061
Start: 2015-10-15End: 2019-03-13Updated: 2020-03-24
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
RecruitingNCT06676410
Start: 2023-07-20End: 2024-12-31Target: 40Updated: 2024-11-06
Unknown Phase
Non-interventional study on the usage and outcomes of CUVITRU in patients with Primary Immunodeficiency Diseases
Active, not recruitingDRKS00014562
Start: 2018-11-27Target: 37Updated: 2025-04-07
German SLD-Registry
Registry for the characterization of patients with steatotic liver disease (SLD)
in Germany
Active, not recruitingDRKS00040904
Start: 2026-07-29Target: 15000Updated: 2026-08-03